To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

March 21, 2024

ACT NOW: Urgent Advocacy Needed for WA State Residents to Expand Access for Cancer Patients

ebci logo

The Washington State Health Care Authority (HCA) has denied coverage for Tumor Treating Fields, preventing Washington Medicaid patients and public employees from accessing this innovative therapy. Referencing current data and clinical evidence, we are working on a campaign to request the HCA take measures to revisit its initial ruling and ensure that Medicaid patients and public employees are afforded access to Tumor Treating Fields.

Glioblastoma is terminal, and the options for patients with this devastating cancer are limited. Patients need as many tools in their toolbox as possible to treat this disease. A treatment that has been approved by the FDA should be accessible for patients no matter their income level, what state they live in, or who their employers are.

We know that creating a groundswell of support can help encourage decision makers to act. Part of what makes us successful is identifying key individuals who can make a compelling case for why innovative technology needs to be included and reimbursed by state programs like the HCA. Click the button below to team up with the End Brain Cancer Initiative as an advocate for expanded access for cancer patients.

The financial weight of health care is a heavy burden. Without proper coverage, innovative care simply isn’t accessible for most patients. These are people who are fighting for their lives, and when opportunities to extend life are taken away, it leaves them without hope.

Raise your voice to advocate for cancer patients in Washington State by clicking the button below.

Dellann Secondary Headshot 2024

Sponsor logos

Hand holding cell phone displaying app


to download EBCI's Disease Education Mobile App


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram